Keywords
Reproduction number, effective reproductive number, COVID-19, American countries
This article is included in the Emerging Diseases and Outbreaks gateway.
This article is included in the DO NOT USE old GW area collection.
This article is included in the Coronavirus collection.
Reproduction number, effective reproductive number, COVID-19, American countries
On January 21, the first case of COVID-19 in the United States1 was announced in a traveler who had arrived in the country from China 5 days earlier. Wuhan, China is where the health emergency originated2 in December 2019. From late January, the North American continent started to see case reports in different states, with cases arriving in South America on February 26 through Brazil after passing through Central America and the Caribbean3. Today, America is the epicentre of the pandemic, with the USA and Brazil being the two largest countries with the most cases. In addition, Peru, Chile, Mexico, Canada, Colombia and Ecuador are among the top 25 countries with the highest incidence worldwide.
Since then, governments across the region have implemented a series of non-pharmacological measures to protect their citizens and contain the spread of COVID-19. All South American countries, including the French overseas region of French Guiana and the Falkland Islands, have reported the presence of coronavirus within their borders, and all took measures at different times of the outbreak.
Non-pharmacological measures of containment (mitigation and suppression) have been implemented from the index case on different dates in each country2,4–6. This is based on projections of contagion and lethality resulting from SIR epidemiological models (susceptible, infected and recovered)7 with data taken from the behavior of the virus in Asia and Europe especially, and with approximations to the basic reproduction number (R0)8,9, effective reproduction number (Re), and variable time estimation of Re (Rt), among others. R0 estimates the speed with which a disease can spread in a population and plays a crucial role in predicting the prevalence of infectious disease, in addition to better understanding an epidemic outbreak and preparing the corresponding public health response. Rt is the reproduction number at time t, which reveals the actual transmission rate of the virus at a given moment. This number will vary depending on the control protocols established in each country.
Mitigation measures are aimed at slowing down the spread of infection by progressively reducing R010. Suppression measures aim to reduce R0 below 1, to progressively decrease the number of cases until they disappear. The greatest challenge that this strategy entails is that it needs to be maintained until the pandemic has disappeared or an effective treatment or vaccine is available6,10,11. The estimation of R0 and Rt in different scenarios allows a better prognosis of the trends of the global epidemic12, in addition to evaluating the effectiveness in reducing transmission with the measures taken by the different countries to contain COVID-1911.
While this article was being prepared, the R0 and Rt values of some countries were published and modeled in three intervention scenarios; however, they only included the United States and Argentina from the American continent, limiting the comparative analysis for the characteristics of America13. Previous work has calculated the R0 and Rt using the maximum likelihood method and sequential Bayesian method, and found that European and North American countries possessed a higher R0 and unsteady Rt fluctuations, whereas some heavily affected Asian countries showed a relatively low R0 and declining Rt , with a small number of patients in Africa and Latin America, yet with the potential risk of large outbreaks. Xu et al.13 who determined Rt as an indicator to measure the transmission of SARS-CoV-2 before and after interventions, showed that the change in the rate of transmission of SARS-CoV-2 is associated with reducing social interactions.
This study aimed to estimate R0 and Rt in multiple countries of the American continent and evaluate their behavior from the first (index) case in each country, and the time of implementation of the chosen non-pharmacological containment measures.
COVID-19 epidemic data were obtained from the Johns Hopkins University data repository (https://coronavirus.jhu.edu/). This information was verified using official country websites, and these websites were also used to collect data about non-pharmacological interventions (Table 1). We selected countries with a relatively high incidence of COVID-19, as follows: Argentina, Bolivia, Brazil, Canada, Colombia, Chile, the Dominican Republic, Ecuador, El Salvador, Guatemala, Honduras, Mexico, Panama, Peru, and the USA. Data were collected from the date on which the first case was reported in the country to June 12, 2020.
We used the COVID-19 daily incidence to estimate the basic reproduction number (R0) and the time-varying reproduction number (Rt) with packages R014 and EpiEstim15 on R software (version 4.0.1), respectively. Rt was calculated using a serial interval (SI) with a mean of 7.5 and a standard deviation of 3.42. The incubation period used was 5 days, taking into account the mean incubation period in 16 of 5.0 days (95% CI, 4.2–6.0), the median incubation period estimated in 17 of 5.1 days (95% CI, 4.5–5.8 days), and the mean incubation period in 2 of 5.2 days (95% CI, 4.1–7.0). We used the maximum likelihood method to estimate both R0 and Rt.
El Salvador, the Dominican Republic, Panama, and Peru have the lowest R0; in contrast, the USA and Canada have the highest. Other countries have an R0 around 1.4 (Figure 1).
Countries could be divided into three groups based on the varied behavior of Rt over time (Figure 2–Figure 4). The first group (Mexico, USA, Colombia and Brazil) started with a high Rt, which decreased post-intervention. In the second group (Canada, Argentina, Chile Peru, Panama and Dominican Republic), the intervention was performed at the moment when the Rt, is high and this then decreased slowly post-intervention. In the third group (Bolivia, Peru and Guatemala), the Rt is erratic and cannot be attributable to the intervention; the Rt increases and decreases without any explanation.
Analysis by regions (North, Central and South America) shows differences between regions and countries. The countries of North America have a low Rt, which increased over time. Post-intervention control is achieved by a progressive decrease in all cases in Canada, Mexico and the USA. The behavior of the Dominican Republic and the countries of Central America is similar. Excepting Bolivia, Guatemala and Peru, the countries of South America and Central America show a similar behavior to the first group; the Rt is high at the beginning and decreases suddenly after control measures. However, Peru had a considerable peak after intervention implementation, as did Chile and Panama. This is possibly related to the flexible measures of mass community isolation
Despite the differences between the first and second group, the Rt is high before the intervention in all countries and its decrease is achieved post-intervention, corroborating the purpose of these interventions in the mitigation and suppression of a pandemic.
The for the countries selected in this study was 1.2–1.8, which is much lower compared to China where it was reported to be 2.2, 2.6, 3.8, or even 6.47 according to different research2,18. Our study findings agree with Xu et al.13 in the estimated for the United States and Argentina. The Rt for these countries is also identical to that found by Xu et al.
As in the study by Xu et al.13, there are some limitations to the current study. First, the variation in depends on the series interval. Here, we assume 7.5 days for the 13 countries due to limited information on the disease in different nations13. In addition, we noticed some errors in the John Hopkins University data when we cross referenced these with official country websites. We were able to correct these by searching for cases directly on the official website of each country. Another drawback is the diversity of RT-PCR (real-time reverse transcription polymerase chain reaction) tests used in the diagnostic process and their sensitivity, which may throw up false negatives, perhaps under-estimating the true impact of the pandemic in various countries. Although data were available from other countries, in the case of Ecuador, the report was not included, because cases were not confirmed by RT-PCR, which is a that s technical criteria.
The epidemic trends in different regions around the world are significantly different due to the great difference in the design and implementation of prevention and control measures5. Estimates of both R0 and Rt in different countries will enable a better forecast of global epidemic trends.
In conclusions, our study shows that there is a close relationship between Rt and non-pharmacological interventions decreed by countries’ governments for the control of the COVID-19 pandemic. Additionally, we showed that there are immediate changes in the behavior of the Rt, and therefore in the progression of the outbreak, when the interventions are implemented closer to the index case for each country.
Zenodo: DataStatistic/COVID19RtAme: Estimation of time-varying reproduction numbers of COVID-19 in American countries, http://doi.org/10.5281/zenodo.395796719.
This project contains the following underlying data:
Data are available under the terms of the Creative Commons Attribution 4.0 International license (CC-BY 4.0).
Views | Downloads | |
---|---|---|
F1000Research | - | - |
PubMed Central
Data from PMC are received and updated monthly.
|
- | - |
Is the work clearly and accurately presented and does it cite the current literature?
No
Is the study design appropriate and is the work technically sound?
Yes
Are sufficient details of methods and analysis provided to allow replication by others?
Yes
If applicable, is the statistical analysis and its interpretation appropriate?
Yes
Are all the source data underlying the results available to ensure full reproducibility?
Yes
Are the conclusions drawn adequately supported by the results?
Yes
Competing Interests: No competing interests were disclosed.
Reviewer Expertise: Anesthesiology, critical care, business in healthcare
Alongside their report, reviewers assign a status to the article:
Invited Reviewers | |
---|---|
1 | |
Version 1 31 Jul 20 |
read |
Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list:
Sign up for content alerts and receive a weekly or monthly email with all newly published articles
Already registered? Sign in
The email address should be the one you originally registered with F1000.
You registered with F1000 via Google, so we cannot reset your password.
To sign in, please click here.
If you still need help with your Google account password, please click here.
You registered with F1000 via Facebook, so we cannot reset your password.
To sign in, please click here.
If you still need help with your Facebook account password, please click here.
If your email address is registered with us, we will email you instructions to reset your password.
If you think you should have received this email but it has not arrived, please check your spam filters and/or contact for further assistance.
Comments on this article Comments (0)